WeTrials
Recruiting

A Phase 1/2, First-in-Human Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of AVZO-021 as a Single Agent and in Combination Therapy in Patients With Advanced Solid Tumors

What is this study?

This early-stage clinical trial is testing a new oral medication called AVZO-021 in people with advanced solid tumors, including certain types of breast and ovarian cancers. Researchers want to see how safe the drug is, find the right dose, and check if it helps fight the cancer.

Who can participate?

Adults aged 18 and older who have advanced solid tumors and are able to carry out most daily activities may be eligible. However, you cannot join if you have recently had certain cancer treatments, major surgery, or if your cancer has spread to your brain or spinal cord.

What will happen?

Participants will take the study medication, and possibly other approved cancer therapies, while closely monitored by the medical team. Doctors will track your health, how your body handles the medicine, and any effects it has on your tumor.

Where and when?

The study is currently recruiting patients and takes place at locations in Connecticut and Florida, United States.

Key Points
  • 1Testing a new cancer medication called AVZO-021 for safety and effectiveness
  • 2Open to adults with certain advanced solid tumors who meet health requirements
  • 3Currently recruiting at multiple locations in the United States

No related links yet

Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Advanced Solid TumorHR+/HER2- Breast CancerHR+, HER2-, Advanced Breast CancerCCNE1 AmplificationEpithelial Ovarian CancerPrimary Peritoneal CancerFallopian Tube CancerEndometrial CancerTNBC - Triple-Negative Breast Cancer

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.